Profound Research and Investment Prospect of China's Generic Drug Market
2012-2016

Profound Research and Investment Prospect of China's Generic Drug Market 2012-2016

By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and better. China's generic drugs can meet the treatment needs of most common diseases and the market share has accounted for more than 85%, at the same time, the health care costs become a large expense in China, the expensive new drugs are facing the growth resistance.

As for the competitive landscape of generic drug sales in different regions, in the advantaged areas such as Beijing, Shanghai, Guangzhou and some other first-tier cities, the foreign investment enterprises and joint ventures occupy an absolute advantage; the annual sales amount of a multinational enterprise in Shanghai Ruijin Hospital reached more than CNY 100 million, this number equivalent to the annual sales level of a medium-sized domestic pharmaceutical enterprise.

In the second-tier cities such as Nanjing, Wuhan and Hangzhou, the domestic brand enterprises formed a strong competitive position, such as Yangtze River Pharmaceutical Group, Harbin Pharmaceutical Group Holding Co., Ltd, Sanjiu Medical & Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd and so on.

In the market of third-tier or four-tier market, especially the rural area markets of counties, villages and towns are flooded with numerous small brands and there is no leading brand in these markets. This means that there are huge opportunities in these markets. If the per capita consumption of drugs in rural market is CNY 120 / year, the rural population in China is nearly 900 million; the market capacity will be CNY 108 billion / year, which means that there are huge opportunities in rural market for generic drugs.

• 1. Overview of China's Generic Drug Product
  • 1.1 Definition, Property and Application Characteristics
  • 1.2 Development History
  • 1.2.1 The First Stage: Old Generic Drug
  • 1.2.2 The Second Stage: New Generic Drug
  • 1.2.3 The Third Stage: Large Generic Drug
• 2. Generic Drug in Overseas Market
  • 2.1 Overview
  • 2.2 The Distribution of Global Marketing Market Sorted by Country
  • 2.3 The Industrial Concentration is High; Competition becomes More and More Fierce
• 3. Circumstance of China's Generic Drug
  • 3.1 Development of China's Economic
  • 3.1.1 Analysis of GDP
  • 3.1.2 Analysis of Fixed Assets Investment
  • 3.1.3 Analysis of Income of Urban and Rural Residents
  • 3.1.4 Forecast of Macro Economic Development in China
  • 3.2 Relevant Industrial Policies, Standards and Laws and Regulations
• 4. Characteristic of Generic Drug
  • 4.1 Analysis and Forecast of Market Concentration Grade
  • 4.2 Analysis of SWOT
  • 4.2.1 Strength
  • 4.2.2 Weakness
  • 4.2.3 Opportunity
  • 4.2.4 Threat
  • 4.3 Enter and Exit Status
  • 4.4 Substitutes
• 5. Development of China's Generic Drug
  • 5.1 Status Quo and Forecast of China's Generic Drug
  • 5.1.1 Market Development Status Quo
  • 5.1.2 Main Distribution Area of Generic Drug Enterprises
  • 5.1.3 Major Multinational Pharmaceutical Enterprises Actively Adjust the New Strategies in China's Generic Drug Market
  • 5.2 Overview of Market Channels
  • 5.3 Market Demand of China's Generic Drug
  • 5.3.1 Demand Characteristics
  • 5.3.2 Consumption Regional Characteristics
  • 5.4 Price Trend of China's Generic Drug
  • 5.4.1 Current Market Price
  • 5.4.2 Factors Affecting Market Price
  • 5.4.3 Forecast of Price Trend
  • 5.5 Basic Characteristic of Promotion
  • 5.5.1 The Recognition is Mature and Have no Necessary to Educate and Promote
  • 5.5.2 The Market is Mature and Have a Huge Market Basis
  • 5.5.3 Price is Mature; the Operational Space is Relatively Small
  • 5.5.4 Channel is Mature and the Channel is willing to Operate
  • 5.5.5 The Categories are too Much, Homogenization Competition is Serious
  • 5.5.6 The Price is Too Transparent
  • 5.5.7 The Approaches are Excessive, Promoting Methods are Similar
  • 5.5.8 Channels Have the Initiative in Hands
• 6. Import and Export of China's Generic Drug
  • 6.1 Growth Speed of Import and Export of Medicine Increased, the Trade Balance Continued to Improve
  • 6.2 The Growth Speed in European and American Markets Slowed Down; the Growth Speed in the Emerging Markets is Rapid
  • 6.3 The Export of Special Bulk Drugs and Western Medicine Increases Rapidly
  • 6.4 The Export of Bulk Drugs Continues to Increase, the Market Share in Global Market Further Improves
  • 6.5 The Export of Prepared Chinese Medicine is Rebound, the Export Volume to EU Started to Decline
• 7. Technical Development of China's Generic Drug
  • 7.1 Development Status Quo
  • 7.2 Technical Maturity Grade
  • 7.3 Technical Gap between China and Foreign Countries and the Reasons
• 8. Main Competitors and Competitive Structure in China
  • 8.1 Harbin Pharmaceutical Group Holding Co., Ltd.
  • 8.2 China Resources Double-crane Pharmaceutical Co., Ltd.
  • 8.3 Yunnan Baiyao Group
  • 8.4 Tasly Group
  • 8.5 Livzon Pharmaceutical Group Inc.
  • 8.6 Qianjin Pharmacy
• 9. Case Study-Shuzhong Pharmacy
  • 9.1 Company Profile
  • 9.2 Low Price Leads to the Cheating on Workmanship and Materials
  • 9.3 Low Price Bid Inviting Mechanism needs the Further Improvement
• 10. Investment Environment and Risks
  • 10.1 Investment Environment
  • 10.2 Investment Risk
• 11. Future Development Forecast and Investment Prediction of Generic Drug in China
  • 11.1 Forecast of Industrial Development Trend
  • 11.2 Forecast of Industrial Operation Situation from 2012 to 2016
  • 11.2.1 Forecast of Gross Industrial Output Value from 2012 to 2016
  • 11.2.2 Forecast of Industrial Sales Revenue from 2012 to 2016
• 12. Investment Suggestions from Industrial Experts
  • 12.1 Marketing Promotion Strategies of Generic Drug Enterprises
  • 12.1.1 Planning the Marketing Path Based on Company Resource
  • 12.1.2 Apply Key Strategies and Choose Key Cities Based on Competitive Advantages and Market Situation
  • 12.1.3 Take Use of the Method of "Manage after Opening" to Manage and Encourage the Working Team
  • 12.1.4 Flexible Use All Kinds of Terminal Sales Promotion Methods Based on Company Resource
  • 12.1.5 Developed Cautiously Based on the Product Characteristics and Resources as for Hospitals, Medical Dispensaries and Clinics
  • 12.2 Opportunity Promotion Strategies of Generic Drug Market